These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10980897)

  • 1. Deactivation of the sympathetic nervous system in patients with chronic congestive heart failure.
    Gilbert EM; Port JD
    Curr Cardiol Rep; 2000 May; 2(3):225-32. PubMed ID: 10980897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
    Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
    Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
    de Peuter OR; Verberne HJ; Kok WE; van den Bogaard B; Schaap MC; Nieuwland R; Meijers JC; Somsen GA; Bakx A; Kamphuisen PW
    J Nucl Med; 2013 Oct; 54(10):1733-9. PubMed ID: 23970363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
    Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
    J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure.
    Ahmed A
    Eur J Heart Fail; 2003 Dec; 5(6):709-15. PubMed ID: 14675848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
    Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
    J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
    Feuerstein G; Ruffolo RR
    Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976
    [No Abstract]   [Full Text] [Related]  

  • 10. Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure.
    Kohno T; Yoshikawa T; Yoshizawa A; Nakamura I; Anzai T; Satoh T; Ogawa S
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):347-55. PubMed ID: 16382297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.
    Gilbert EM; Abraham WT; Olsen S; Hattler B; White M; Mealy P; Larrabee P; Bristow MR
    Circulation; 1996 Dec; 94(11):2817-25. PubMed ID: 8941107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results.
    Doughty RN; Sharpe N
    Annu Rev Med; 1997; 48():103-14. PubMed ID: 9046949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of carvedilol and metoprolol on exercise ventilatory efficiency in patients with congestive heart failure.
    Kataoka M; Satoh T; Yoshikawa T; Nakamura I; Kohno T; Yoshizawa A; Anzai T; Ogawa S
    Circ J; 2008 Mar; 72(3):358-63. PubMed ID: 18296829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
    Arslan S; Erol MK; Bozkurt E; Acikel M; Gundogdu F; Atesal S; Senocak H
    Int J Cardiovasc Imaging; 2007 Oct; 23(5):549-55. PubMed ID: 17171429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol for heart failure: renewed interest in beta blockers.
    Young JB
    Cleve Clin J Med; 1997 Sep; 64(8):415-22. PubMed ID: 9308217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.
    Packer M; Antonopoulos GV; Berlin JA; Chittams J; Konstam MA; Udelson JE
    Am Heart J; 2001 Jun; 141(6):899-907. PubMed ID: 11376302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines and their blockade in congestive heart failure.
    White CM
    Am J Health Syst Pharm; 1998 Apr; 55(7):676-82. PubMed ID: 9558423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gln(27)-->Glubeta(2)-adrenergic receptor polymorphism in heart failure patients: differential clinical and oxidative response to carvedilol.
    Troncoso R; Moraga F; Chiong M; Roldán J; Bravo R; Valenzuela R; Díaz-Araya G; del Campo A; Sanhueza C; Rodriguez A; Vukasovic JL; Mellado R; Greig D; Castro PF; Lavandero S
    Basic Clin Pharmacol Toxicol; 2009 May; 104(5):374-8. PubMed ID: 19422106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.